Showing results (441-450 of 7,628) with videos related to
Sort By:
Pageof 763
American Journal of Hematology|August 1, 1990
Relationship of partially purified factor concentrates to immune tests and AIDS. The Hemophilia-AIDS. Collaborative Study GroupJ Jason, R C Holman, B L EvattAmerican Journal of Hematology|November 17, 2010
C-MYC rearrangement may induce an aggressive phenotype in anaplastic lymphoma kinase positive anaplastic large cell lymphoma: Identification of a novel fusion gene ALO17/C-MYCHiroshi Moritake, Hidemi Shimonodan, Kousuke Marutsuka, et al.American Journal of Hematology|May 1, 1990
Surface light chain phenotype in indolent lymphomas: lack of prognostic significanceL A VanderMolen, P L Duffey, J Cossman, et al.American Journal of Hematology|October 1, 2010
Urinary markers of bone resorption, pyridinoline and deoxypyridinoline, are increased in sickle cell patients with further increments during painful crisisErfan Nur, Willem Mairuhu, Bart J Biemond, et al.American Journal of Hematology|October 1, 2010
Comprehensive evaluation of time-to-response parameter as a predictor of treatment failure following imatinib therapy in chronic phase chronic myeloid leukemia: which parameter at which time-point does matter?Dong Hwan ' Dennis ' Kim, Lakshmi Sriharsha, Chul Won Jung, et al.American Journal of Hematology|September 28, 2010
Comparison of real-time microvascular abnormalities in pediatric and adult sickle cell anemia patientsAnthony T W Cheung, Joshua W Miller, Sarah M Craig, et al.American Journal of Hematology|September 28, 2010
Identical IGHV-D-J gene rearrangement may precede the clinical onset of chronic lymphocytic leukemia by several yearsMaurizio Frezzato, Ilaria Giaretta, Domenico Madeo, et al.American Journal of Hematology|September 28, 2010
Second-line mitoxantrone, etoposide, and cytarabine for acute myeloid leukemia: a single-center experienceHolbrook E Kohrt, Samit Patel, Michelle Ho, et al.American Journal of Hematology|August 28, 2010
Follow-up report on the 2-year cardiac data from a deferasirox monotherapy trialJohn C Wood, Tara Glynos, Alexis Thompson, et al.American Journal of Hematology|August 24, 2010
Long-term results of single-agent thalidomide as initial therapy for asymptomatic (smoldering or indolent) myelomaKristen Detweiler-Short, Suzanne Hayman, Morie A Gertz, et al.Pageof 763